C. Alix‐Panabières

Oncology · 2010–2021

A researcher in the Science corpus: 6 papers; trusts 8 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Oncology — 117 citations into it; #669 of 1,698 by trust here, #881 by citations
• Cancer Research — 100 citations into it; #740 of 1,780 by trust here, #999 by citations
• Pulmonary and Respiratory Medicine — 40 citations into it
• Molecular Biology — 37 citations into it; #13,338 of 17,773 by trust here, #12,008 by citations
• Pathology and Forensic Medicine — 28 citations into it

Whom C. Alix‐Panabières trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. K. Pantel
2. Eleftherios P. Diamandis
3. L. Diaz
4. H. Schwarzenbach
5. Christophe Klein
6. Raghu Kalluri
7. Yang Liu
8. W. Tam
9. R. Weinberg
10. D. Hoon

Who trusts C. Alix‐Panabières overall

1. K. Pantel

Papers from C. Alix‐Panabières's perspective

Ordered by how strongly the researchers C. Alix‐Panabières trusts endorse each paper. Same corpus, a different order for every researcher.

1. Systemic spread is an early step in breast cancer. (Cancer Cell)
2. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip (Proceedings of the National Academy of Sciences of the United States of America)
3. Genome-wide cell-free DNA fragmentation in patients with cancer (Nature)
4. Circulating Tumor Cell Clusters are Oligoclonal Precursors of Breast Cancer Metastasis (Cell)
5. Liquid biopsy and minimal residual disease — latest advances and implications for cure (Nature Reviews Clinical Oncology)
6. Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence (New England Journal of Medicine)
7. The epithelial-mesenchymal transition generates cells with properties of stem cells. (Cell)
8. Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling (Cancer Discovery)
9. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA (Annals of Oncology)
10. Targeting metastatic cancer (Nature Medicine)

Their papers

• Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy. (2016) — 1,205 citations
• Liquid biopsy and minimal residual disease — latest advances and implications for cure (2019) — 938 citations
• Circulating tumor cells: liquid biopsy of cancer. (2013) — 667 citations
• Liquid Biopsy: From Discovery to Clinical Application. (2021) — 695 citations
• Challenges in circulating tumour cell research (2014) — 1,227 citations
• Circulating tumour cells in cancer patients: challenges and perspectives. (2010) — 769 citations